Skip to main content

Table 1 Out of a total of 9951 patients presenting with cardiac CEDIS complaints, 82.1 and 81.9% of patients, respectively, had hsTnT and CK measured. Chest Pain (Cardiac Features) prompted biomarker testing most frequently. 1.2% of patients presenting to the ED were subsequently admitted with diagnoses of NSTE-ACS. hsTnT; high-sensitivity troponin T, CK; creatine kinase, NSTE-ACS; non-ST-elevation ACS

From: Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes

  Total Patients Prevalence (n = 36,251) hsTnT Measured CK Measured
Chest Pain 404 1.1% 96.3% 95.8%
Chest Pain (Cardiac Features) 3555 9.8% 97.6% 97.4%
Chest Pain (Non-cardiac Features) 1040 2.9% 67.5% 67.4%
Generalized Weakness 746 2.1% 62.6% 62.9%
Palpitations 1033 2.8% 88.2% 87.8%
Shortness of Breath 1600 4.4% 68.2% 68.2%
Syncope 709 2.0% 75.9% 75.7%
Vertigo 437 1.2% 39.6% 39.1%
Admitted with NSTE-ACS (any CEDIS complaint) 427 1.2% 100% 100%
Combined 9951 27.5% 82.1% 81.9%